The protective effect of low-dose methotrexate on ischemia-reperfusion injury of the rabbit spinal cord

European Journal of Pharmacology

Volumn 714, Issue 1-3, 2013, Pages 148-156

  Kertmen, Hayri ^a   Gürer, Bora ^a   Yilmaz, Erdal Reşit ^a   Şanli, Ahmet Metin ^a   Sorar, Mehmet ^a   Arkök, Ata Türker ^a   Sargon, Mustafa Fevzi ^b   Kanat, Mehmet Ali ^c   Ergüder, Berrin Imge ^d   Şekerci, Zeki ^a  

^a DISKAPI YILDIRIM BEYAZIT TRAINING AND RESEARCH HOSPITAL   (Turkey)

^b HACETTEPE UNIVERSITY   (Turkey)

^c MINISTRY OF HEALTH   (Turkey)

^d ANKARA UNIVERSITY   (Turkey)

Author keywords

Adenosine; Ischemia reperfusion; Methotrexate; Methylprednisolone; Neuroprotection; Spinal cord

Indexed keywords

CASPASE 3; CATALASE; MALONALDEHYDE; METHOTREXATE; METHYLPREDNISOLONE; METOART; MYELOPEROXIDASE; UNCLASSIFIED DRUG; XANTHINE OXIDASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; HISTOPATHOLOGY; LAPAROTOMY; LOW DRUG DOSE; NEUROLOGIC EXAMINATION; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RABBIT; SCORING SYSTEM; SINGLE DRUG DOSE; SPINAL CORD INJURY; SPINAL CORD ISCHEMIA; TARLOV SCORE; TISSUE LEVEL; ULTRASTRUCTURE;

ADENOSINE; ISCHEMIA-REPERFUSION; METHOTREXATE; METHYLPREDNISOLONE; NEUROPROTECTION; SPINAL CORD;

ANIMALS; CASPASE 3; CATALASE; DOSE-RESPONSE RELATIONSHIP, DRUG; MALE; MALONDIALDEHYDE; METHOTREXATE; METHYLPREDNISOLONE; PEROXIDASE; RABBITS; REPERFUSION INJURY; SPINAL CORD; XANTHINE OXIDASE;

EID: 84880181636     PISSN: 00142999     EISSN: 18790712     Source Type: Journal    
DOI: 10.1016/j.ejphar.2013.05.012     Document Type: Article

References (49)

1. Aebi, H., 1984. Catalase in vitro. Methods Enzymol. 105, 121-126.
2. Agee, J.M., Flanagan, T., Blackbourne, L.H., Kron, I.L., Tribble, C.G., 1991. Reducing postischemic paraplegia using conjugated superoxide dismutase. Ann. Thorac. Surg. 51, 911-914.
3. Asanuma, H., Sanada, S., Ogai, A., Minamino, T., Takashima, S., Asakura, M., Ogita, H., Shinozaki, Y., Mori, H., Node, K., Tomoike, H., Hori, M., Kitakaze, M., 2004. Methotrexate and MX-68, a new derivative of methotrexate, limit infarct size via adenosine-dependent mechanisms in canine hearts. J. Cardiovasc. Pharmacol. 43, 574-579. (Pubitemid 39090024)
4. Cassada, D.C., Tribble, C.G., Laubach, V.E., Nguyen, B.N., Rieger, J.M., Linden, J., Kaza, A.K., Long, S.M., Kron, I.L., Kern, J.A., 2001a. An adenosine A2A agonist, ATL-146e, reduces paralysis and apoptosis during rabbit spinal cord reperfusion. J. Vasc. Surg. 34, 482-488. (Pubitemid 33661182)
5. Cassada, D.C., Gangemi, J.J., Rieger, J.M., Linden, J., Kaza, A.K., Long, S.M., Kron, I.L., Tribble, C.G., Kern, J.A., 2001b. Systemic adenosine A2A agonist ameliorates ischemic reperfusion injury in the rabbit spinal cord. Ann. Thorac. Surg. 72, 1245-1250. (Pubitemid 32938015)
6. Chan, P.H., 1996. Role of oxidants in ischemic brain damage. Stroke 27, 1124-1129. (Pubitemid 26177617)
7. Crawford, E.S., Crawford, J.L., Safi, H.J., Coselli, J.S., Hess, K.R., Brooks, B., Norton, H.J., Glaeser, D.H., 1986. Thoracoabdominal aortic aneurysms: preoperative and intraoperative factors determining immediate and long-term results of operations in 605 patients. J. Vasc. Surg. 3, 389-404. (Pubitemid 16164040)
8. Cronstein, B.N., Eberle, M.A., Gruber, H.E., Levin, R.I., 1991. Methotrexate inhibits neutrophil function by stimulating adenosine release from connective tissue cells. Proc. Nat. Acad. Sci. U.S.A. 88, 1445-2441.
9. Cronstein, B.N., Naime, D., Ostad, E., 1993. The antiinflammatory mechanism of methotrexate. Increased adenosine release at inflamed sites diminishes leukocyte accumulation in an in vivo model of inflammation. J. Clin. Invest. 92, 2675-2682. (Pubitemid 24006532)
10. Dalmarco, E.M., Fröde, T.S., Medeiros, Y.S., 2002. Effects of methotrexate upon inflammatory parameters induced by carrageenan in the mouse model of pleurisy. Mediators Inflamm. 11, 299-306. (Pubitemid 35335220)
11. Diaz-Ruiz, A., Rios, C., Duarte, I., Correa, D., Guizar-Sahagun, G., Grijalva, I., Madrazo, I., Ibarra, A., 2000. Lipid peroxidation inhibition in spinal cord injury: cyclosporin - A vs methylprednisolone. Neuroreport 11, 1765-1767. (Pubitemid 30350349)
12. Di Paola, R., Melani, A., Esposito, E., Mazzon, E., Paterniti, I., Bramanti, P., Pedata, F., Cuzzocrea, S., 2010. Adenosine A2A receptor-selective stimulation reduces signaling pathways involved in the development of intestine ischemia and reperfusion injury. Shock 33, 541-551.
13. Dumont, R.J., Okonkwo, D.O., Verma, S., Hurlbert, R.J., Boulos, P.T., Ellegala, D.B., Dumont, A.S., 2001. Acute spinal cord injury, part I: Pathophysiologic mechanisms. Clin. Neuropharmacol. 24, 254-264. (Pubitemid 32906712)
14. Fan, L., Wang, K., Shi, Z., Die, J., Wang, C., Dang, X., 2011. Tetramethylpyrazine protects spinal cord and reduces inflammation in a rat model of spinal cord ischemia-reperfusion injury. J. Vasc. Surg. 54, 192-200.
15. Fansa, I., Altug, M.E., Melek, I., Ucar, E., Kontas, T., Akcora, B., Atik, E., Duman, T., 2009. The neuroprotective and anti-inflammatory effects of diltiazem in spinal cord ischaemia-reperfusion injury. J. Int. Med. Res. 37, 520-533.
16. Genestier, L., Paillot, R., Fournel, S., Ferraro, C., Miossec, P., Revillard, J.P., 1998. Immunosuppressive properties of methotrexate: apoptosis and clonal deletion of activated peripheral T cells. J. Clin. Invest. 102, 322-328. (Pubitemid 28335191)
17. Genovese, T., Melani, A., Esposito, E., Paterniti, I., Mazzon, E., Di Paola, R., Bramanti, P., Linden, J., Pedata, F., Cuzzocrea, S., 2010. Selective adenosine A(2a) receptor agonists reduce the apoptosis in an experimental model of spinal cord trauma. J. Biol. Regul. Homeost. Agents 24, 73-86.
18. Haskó, G., Cronstein, B.N., 2004. Adenosine: an endogenous regulator of innate immunity. Trends Immunol. 25, 33-39. (Pubitemid 38032805)
19. Hasturk, A., Atalay, B., Calisaneller, T., Ozdemir, O., Oruckaptan, H., Altinors, N., 2009. Analysis of serum pro-inflammatory cytokine levels after rat spinal cord ischemia/reperfusion injury and correlation with tissue damage. Turk. Neurosurg. 19, 353-359.
20. Hille, R., Nishino, T., 1995. Flavoprotein structure and mechanism. 4. Xanthine oxidase and xanthine dehydrogenase. FASEB J. 9, 995-1003.
21. Hirose, K., Okajima, K., Uchiba, M., Nakano, K.Y., Utoh, J., Kitamura, N., 2004. Antithrombin reduces the ischemia/reperfusion-induced spinal cord injury in rats by attenuating inflammatory responses. Thromb. Haemost. 91, 162-170. (Pubitemid 38111233)
22. Ilhan, A., Yilmaz, H.R., Armutcu, F., Gurel, A., Akyol, O., 2004. The protective effect of nebivolol on ischemia/reperfusion injury in rabbit spinal cord. Prog. Neuro-psychopharmacol. Biol. Psychiatry 28, 1153-1160. (Pubitemid 40017632)
23. Johnston, A., Gudjonsson, J.E., Sigmundsdottir, H., Ludviksson, B.R., Valdimarsson, H., 2005. The anti-inflammatory action of methotrexate is not mediated by lymphocyte apoptosis, but by the suppression of activation and adhesion molecules. Clin. Immunol. 114, 154-163. (Pubitemid 40082381)
24. Kanellopoulos, G.K., Kato, H., Wu, Y., Dougenis, D., Mackey, M., Hsu, C.Y., Kouchoukos, N.T., 1997. Neuronal cell death in the ischemic spinal cord: the effect of methylprednisolone. Ann. Thorac. Surg. 64, 1279-1285.
25. Kaptanoglu, E., Palaoglu, S., Surucu, H.S., Hayran, M., Beskonakli, E., 2002. Ultrastructural scoring of graded acute spinal cord injury in the rat. J. Neurosurg. 97, 49-56. (Pubitemid 34686600)
26. Keane, R.W., Kraydieh, S., Lotocki, G., Bethea, J.R., Krajewski, S., Reed, J.C., Dietrich, W.D., 2001. Apoptotic and anti-apoptotic mechanisms following spinal cord injury. J. Neuropathol. Exp. Neurol. 60, 422-429. (Pubitemid 32467099)
27. Krieglstein, C.F., Granger, D.N., 2001. Adhesion molecules and their role in vascular disease. Am. J. Hypertens. 14 (6 Pt 2), 44S-54S. (Pubitemid 32506696)
28. Li, C., Zhao, R., Gao, K., Wei, Z., Yin, M.Y., Lau, L.T., Chui, D., Hoi, Yu, A.C., 2011. Astrocytes: implications for neuroinflammatory pathogenesis of Alzheimer's disease. Curr. Alzheimer. Res. 8, 67-80.
29. Lu, K., Cho, C.L., Liang, C.L., Chen, S.D., Liliang, P.C., Wang, S.Y., Chen, H.J., 2007. Inhibition of the MEK/ERK pathway reduces microglial activation and interleukin-1-beta expression in spinal cord ischemia/reperfusion injury in rats. J. Thorac. Cardiovasc. Surg. 133, 934-941. (Pubitemid 46435929)
30. Lukácová, N., Halát, G., Chavko, M., Marsala, J., 1996. Ischemia-reperfusion injury in the spinal cord of rabbits strongly enhances lipid peroxidation and modifies phospholipid profiles. Neurochem. Res. 21, 869-873. (Pubitemid 126724485)
31. Matsumoto, S., Matsumoto, M., Yamashita, A., Ohtake, K., Ishida, K., Morimoto, Y., Sakabe, T., 2003. The temporal profile of the reaction of microglia, astrocytes, and macrophages in the delayed onset paraplegia after transient spinal cord ischemia in rabbits. Anesth. Analg. 96, 1777-1784. (Pubitemid 36623141)
32. Mitchell, M.S., Wade, M.E., DeConti, R.C., Bertino, J.R., Calabresi, P., 1969. Immuno-suppressive effects of cytosine arabinoside and methotrexate in man. Ann. Intern. Med. 70, 535-547.
33. Montesinos, M.C., Desai, A., Delano, D., Chen, J.F., Fink, J.S., Jacobson, M.A., Cronstein, B.N., 2003. Adenosine A2A or A3 receptors are required for inhibition of inflammation by methotrexate and its analog MX-68. Arthritis Rheum. 48, 240-247. (Pubitemid 36091669)
34. Montesinos, M.C., Takedachi, M., Thompson, L.F., Wilder, T.F., Fernández, P., Cronstein, B.N., 2007. The anti-inflammatory mechanism of methotrexate depends on extracellular conversion of adenine nucleotides to adenosine by ecto-5'-nucleotidase: findings in a study of ecto-5'-nucleotidase gene-deficient mice. Arthritis Rheum. 56, 1440-1445. (Pubitemid 46764071)
35. Naidu, K.A., Fu, E.S., Sutton, E.T., Prockop, L.D., Cantor, A., 2003. The therapeutic effects of epidural intercellular adhesion molecule-1 monoclonal antibody in a rabbit model: involvement of the intercellular adhesion molecule-1 pathway in spinal cord ischemia. Anesth. Analg. 97, 857-862. (Pubitemid 37046460)
36. Paterniti, I., Melani, A., Cipriani, S., Corti, F., Mello, T., Mazzon, E., Esposito, E., Bramanti, P., Cuzzocrea, S., Pedata, F., 2011. Selective adenosine A2A receptor agonists and antagonists protect against spinal cord injury through peripheral and central effects. J. Neuroinflammation 8, 31.
37. Prajda, N., Weber, G., 1975. Malignant transformation-linked imbalance: decreased xanthine oxidase activity in hepatomas. FEBS Lett. 59, 245-249.
38. Qian, H., Liu, D., 1997. The time course of malondialdehyde production following impact injury to rat spinal cord as measured by microdialysis and high pressure liquid chromatography. Neurochem. Res. 22, 1231-1236. (Pubitemid 27440791)
39. Reece, T.B., Okonkwo, D.O., Ellman, P.I., Warren, P.S., Smith, R.L., Hawkins, A.S., Linden, J., Kron, I.L., Tribble, C.G., Kern, J.A., 2004. The evolution of ischemic spinal cord injury in function, cytoarchitecture, and inflammation and the effects of adenosine A2A receptor activation. J. Thorac. Cardiovasc. Surg. 128, 925-932. (Pubitemid 39575299)
40. Sanli, A.M., Serbes, G., Sargon, M.F., Calişkan, M., Kilinç, K., Bulut, H., Sekerci, Z., 2012. Methothrexate attenuates early neutrophil infiltration and the associated lipid peroxidation in the injured spinal cord but does not induce neurotoxicity in the uninjured spinal cord in rats. Acta. Neurochir. (Wien) 154, 1045-1054.
41. Schwab, M.E., Bartholdi, D., 1996. Degeneration and regeneration of axons in the lesioned spinal cord. Physiol. Rev. 76, 319-370. (Pubitemid 26163712)
42. Taoka, Y., Okajima, K., Uchiba, M., Murakami, K., Kushimoto, S., Johno, M., Naruo, M., Okabe, H., Takatsuki, K., 1997. Role of neutrophils in spinal cord injury in the rat. Neuroscience 79, 1177-1182. (Pubitemid 27293767)
43. Ueno, T., Furukawa, K., Katayama, Y., Suda, H., Itoh, T., 1994. Spinal cord protection: development of a paraplegia-preventive solution. Ann. Thorac. Surg. 58, 116-120. (Pubitemid 24243915)
44. Umehara, S., Goyagi, T., Nishikawa, T., Tobe, Y., Masaki, Y., 2010. Esmolol and landiolol, selective beta1-adrenoreceptor antagonists, provide neuroprotection against spinal cord ischemia and reperfusion in rats. Anesth. Analg. 110, 1133-1137.
45. Ustün, M.E., Duman, A., Oǧun, C.O., Vatansev, H., Ak, A., 2001. Effects of nimodipine and magnesium sulfate on endogenous antioxidant levels in brain tissue after experimental head trauma. J. Neurosurg. Anesthesiol. 13, 227-232. (Pubitemid 32606418)
46. Weinblatt, M.E., Coblyn, J.S., Fox, D.A., Fraser, P.A., Holdsworth, D.E., Glass, D.N., Trentham, D.E., 1985. Efficacy of low-dose methotrexate in rheumatoid arthritis. N. Engl. J. Med. 312, 818-822. (Pubitemid 15104774)
47. Wessels, J.A., Huizinga, T.W., Guchelaar, H.J., 2008. Recent insights in the pharmacological actions of methotrexate in the treatment of rheumatoid arthritis. Rheumatology (Oxford) 47, 249-255. (Pubitemid 351267187)
48. Yilmaz, E.R., Kertmen, H., Dolgun, H., Gürer, B., Sanli, A.M., Kanat, M.A., Arikok, A.T., Bahsi, S.Y., Ergüder, B.I., Sekerci, Z., 2012. Effects of darbepoetin-alpha in spinal cord ischemia-reperfusion injury in the rabbit. Acta. Neurochir. (Wien) 154, 1037-1043.
49. Zivin, J.A., DeGirolami, U., 1980. Spinal cord infarction: a highly reproducible stroke model. Stroke 11, 200-202. (Pubitemid 10133608)